An Action Plan for Tuberculosis in England

[www.who.int/mediacentre/factsheets/fs104/en] Accessed 11 March 2005

[www.hpa.org.uk/infections/topicas_az/tb/menu.htm] Accessed 11 March 2005

Donaldson L. Stopping Tuberculosis in England. London: Department of Health, 2004

Frieden T.R. , Fujiwara P.I. , Washko R. , Hamburg M.A. Tuberculosis in New York City—turning the tide. N Engl J Med 1995; 333: 229–33

Ewer K. , Deeks J. , Alvarez L. . Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168–73

Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53: 536–48

Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000; 55: 887–901

Rubin E.J. Towards a new therapy for tuberculosis. N Engl J Med 2005; 352: 933–4

McShane H. , Pathan A.A. , Sander C.R. . Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nature Med 2004; 10: 1240

Davies P. BCG: is it time to phase it out? Airways J 2003; 11: 184–6

Ruddy M.C. , Davies A.P. , Yates M.D. . Outbreak of isoniazid resistant tuberculosis in north London. Thorax 2004; 59: 279–85

Davies P.D.O. Molecular epidemiology unmasks the tubercle bacillus: new techniques reveal new aspects of virulence. Thorax 2004; 59: 273–4